bioAffinity Technologies, Inc. (BIAFW) stock
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
bioAffinity Technologies total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
bioAffinity Technologies's total debt was $36.47K at Jun 30, 2026. For fiscal 2025 it was $41.31K, up 104.7% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.31K | +104.7% |
| FY2024 | Dec 31, 2024 | $20.18K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $36.47K | -20.6% |
| Q1 FY2026 | Mar 31, 2026 | $38.92K | -19.2% |
| Q4 FY2025 | Dec 31, 2025 | $41.31K | +104.7% |
| Q3 FY2025 | Sep 30, 2025 | $303.66K | +103.6% |
| Q2 FY2025 | Jun 30, 2025 | $45.95K | +101.8% |
| Q1 FY2025 | Mar 31, 2025 | $48.16K | +109.0% |
| Q4 FY2024 | Dec 31, 2024 | $20.18K | – |
| Q3 FY2024 | Sep 30, 2024 | $149.18K | – |
| Q2 FY2024 | Jun 30, 2024 | $22.77K | – |
| Q1 FY2024 | Mar 31, 2024 | $23.04K | – |